Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Sep 1;147(5):697–712.

Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.

PMCID: PMC1336391  PMID: 1521215

Full text

PDF
697

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti K. G., Gries F. A. Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med. 1988 Apr;5(3):275–281. doi: 10.1111/j.1464-5491.1988.tb00984.x. [DOI] [PubMed] [Google Scholar]
  2. Andres R. Effect of obesity on total mortality. Int J Obes. 1980;4(4):381–386. [PubMed] [Google Scholar]
  3. Bennett P. H. Diabetes in the elderly: diagnosis and epidemiology. Geriatrics. 1984 May;39(5):37–41. [PubMed] [Google Scholar]
  4. Berger W., Caduff F., Pasquel M., Rump A. Die relative Häufigkeit der schweren Sulfonylharnstoff-Hypoglykämie in den letzten 25 Jahren in der Schweiz. Resultat von zwei gesamtschweizerischen Umfragen in den Jahren 1969 und 1984. Schweiz Med Wochenschr. 1986 Feb 1;116(5):145–151. [PubMed] [Google Scholar]
  5. Bobrov V. A., Beziuk N. N., Davydova I. V. Bezbolevaia ishemiia miokarda (obzor literatury). Vrach Delo. 1991 Feb;(2):16–23. [PubMed] [Google Scholar]
  6. Bogardus C., Ravussin E., Robbins D. C., Wolfe R. R., Horton E. S., Sims E. A. Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes. 1984 Apr;33(4):311–318. doi: 10.2337/diab.33.4.311. [DOI] [PubMed] [Google Scholar]
  7. Brown S. A. Studies of educational interventions and outcomes in diabetic adults: a meta-analysis revisited. Patient Educ Couns. 1990 Dec;16(3):189–215. doi: 10.1016/0738-3991(90)90070-2. [DOI] [PubMed] [Google Scholar]
  8. Chockalingam A., Abbott D., Bass M., Battista R., Cameron R., de Champlain J., Evans C. E., Laidlaw J., Lee B. L., Leiter L. Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia. CMAJ. 1990 Jun 15;142(12):1397–1409. [PMC free article] [PubMed] [Google Scholar]
  9. Clarke B. F., Campbell I. W. Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics. Lancet. 1975 Feb 1;1(7901):246–248. doi: 10.1016/s0140-6736(75)91141-1. [DOI] [PubMed] [Google Scholar]
  10. Colwell J. A., Bingham S. F., Abraira C., Anderson J. W., Comstock J. P., Kwaan H. C., Nuttall F. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care. 1986 Mar-Apr;9(2):140–148. doi: 10.2337/diacare.9.2.140. [DOI] [PubMed] [Google Scholar]
  11. Coustan D. R. Diagnosis of gestational diabetes. What are our objectives? Diabetes. 1991 Dec;40 (Suppl 2):14–17. doi: 10.2337/diab.40.2.s14. [DOI] [PubMed] [Google Scholar]
  12. Dorman J. S., Laporte R. E., Kuller L. H., Cruickshanks K. J., Orchard T. J., Wagener D. K., Becker D. J., Cavender D. E., Drash A. L. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984 Mar;33(3):271–276. doi: 10.2337/diab.33.3.271. [DOI] [PubMed] [Google Scholar]
  13. Drash A. L. Diabetes mellitus in the child and adolescent: Part II. Curr Probl Pediatr. 1986 Sep;16(9):469–542. doi: 10.1016/0045-9380(86)90010-1. [DOI] [PubMed] [Google Scholar]
  14. Drexel H., Bichler A., Sailer S., Breier C., Lisch H. J., Braunsteiner H., Patsch J. R. Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus. Diabetes Care. 1988 Nov-Dec;11(10):761–768. doi: 10.2337/diacare.11.10.761. [DOI] [PubMed] [Google Scholar]
  15. Dyck P. J. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988 Jan;11(1):21–32. doi: 10.1002/mus.880110106. [DOI] [PubMed] [Google Scholar]
  16. Evers S., McCracken E., Antone I., Deagle G. The prevalence of diabetes in Indians and Caucasians living in southwestern Ontario. Can J Public Health. 1987 Jul-Aug;78(4):240–243. [PubMed] [Google Scholar]
  17. Fantus I. G., Brosseau R. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. J Clin Endocrinol Metab. 1986 Oct;63(4):898–905. doi: 10.1210/jcem-63-4-898. [DOI] [PubMed] [Google Scholar]
  18. Floyd J. C., Jr, Funnell M. M., Kazi I., Templeton C. Feasibility of adjustment of insulin dose by insulin-requiring type II diabetic patients. Diabetes Care. 1990 Apr;13(4):386–392. doi: 10.2337/diacare.13.4.386. [DOI] [PubMed] [Google Scholar]
  19. Fuhrmann K., Reiher H., Semmler K., Fischer F., Fischer M., Glöckner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care. 1983 May-Jun;6(3):219–223. doi: 10.2337/diacare.6.3.219. [DOI] [PubMed] [Google Scholar]
  20. Gabbe S. G. Management of diabetes mellitus in pregnancy. Am J Obstet Gynecol. 1985 Dec 15;153(8):824–828. doi: 10.1016/0002-9378(85)90683-0. [DOI] [PubMed] [Google Scholar]
  21. Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974 Feb;23(2):105–111. doi: 10.2337/diab.23.2.105. [DOI] [PubMed] [Google Scholar]
  22. Garg A., Grundy S. M. Management of dyslipidemia in NIDDM. Diabetes Care. 1990 Feb;13(2):153–169. doi: 10.2337/diacare.13.2.153. [DOI] [PubMed] [Google Scholar]
  23. Gerich J. E. Oral hypoglycemic agents. N Engl J Med. 1989 Nov 2;321(18):1231–1245. doi: 10.1056/NEJM198911023211805. [DOI] [PubMed] [Google Scholar]
  24. Groop L. C., Groop P. H., Stenman S. Combined insulin-sulfonylurea therapy in treatment of NIDDM. Diabetes Care. 1990 Aug;13 (Suppl 3):47–52. doi: 10.2337/diacare.13.3.47. [DOI] [PubMed] [Google Scholar]
  25. Gundersen T., Kjekshus J. Timolol treatment after myocardial infarction in diabetic patients. Diabetes Care. 1983 May-Jun;6(3):285–290. doi: 10.2337/diacare.6.3.285. [DOI] [PubMed] [Google Scholar]
  26. Hadrava V., Kruppa U., Russo R. C., Lacourcière Y., Tremblay J., Hamet P. Vascular smooth muscle cell proliferation and its therapeutic modulation in hypertension. Am Heart J. 1991 Oct;122(4 Pt 2):1198–1203. doi: 10.1016/0002-8703(91)90939-f. [DOI] [PubMed] [Google Scholar]
  27. Hamet P., Kalant N., Ross S. A., Wilson T. W., Leenen F. H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. CMAJ. 1988 Dec 1;139(11):1059–1062. [PMC free article] [PubMed] [Google Scholar]
  28. Harris M. I. Impaired glucose tolerance in the U.S. population. Diabetes Care. 1989 Jul-Aug;12(7):464–474. doi: 10.2337/diacare.12.7.464. [DOI] [PubMed] [Google Scholar]
  29. Hermann L. S. Biguanides and sulfonylureas as combination therapy in NIDDM. Diabetes Care. 1990 Aug;13 (Suppl 3):37–41. doi: 10.2337/diacare.13.3.37. [DOI] [PubMed] [Google Scholar]
  30. Houston M. C. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Am Heart J. 1989 Apr;117(4):911–951. doi: 10.1016/0002-8703(89)90631-5. [DOI] [PubMed] [Google Scholar]
  31. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  32. Kesson C. M., Bailie G. R. Do diabetic patients inject accurate doses of insulin? Diabetes Care. 1981 Mar-Apr;4(2):333–333. doi: 10.2337/diacare.4.2.333a. [DOI] [PubMed] [Google Scholar]
  33. Kitzmiller J. L., Gavin L. A., Gin G. D., Jovanovic-Peterson L., Main E. K., Zigrang W. D. Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA. 1991 Feb 13;265(6):731–736. [PubMed] [Google Scholar]
  34. Klein B. E., Klein R., Meuer S. M., Moss S. E., Dalton D. D. Does the severity of diabetic retinopathy predict pregnancy outcome? J Diabet Complications. 1988 Oct-Dec;2(4):179–184. doi: 10.1016/s0891-6632(88)80005-9. [DOI] [PubMed] [Google Scholar]
  35. Klein B. E., Moss S. E., Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990 Jan;13(1):34–40. doi: 10.2337/diacare.13.1.34. [DOI] [PubMed] [Google Scholar]
  36. Klein R., Klein B. E., Moss S. E., Davis M. D., DeMets D. L. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA. 1988 Nov 18;260(19):2864–2871. [PubMed] [Google Scholar]
  37. Klein R., Klein B. E., Moss S. E., Davis M. D., DeMets D. L. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med. 1989 Nov;149(11):2427–2432. [PubMed] [Google Scholar]
  38. Klein R., Klein B. E., Moss S. E., Davis M. D., DeMets D. L. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984 Apr;102(4):520–526. doi: 10.1001/archopht.1984.01040030398010. [DOI] [PubMed] [Google Scholar]
  39. Klein R., Klein B. E., Moss S. E., DeMets D. L. The validity of a survey question to study diabetic retinopathy. Am J Epidemiol. 1986 Jul;124(1):104–110. doi: 10.1093/oxfordjournals.aje.a114353. [DOI] [PubMed] [Google Scholar]
  40. Klein R., Klein B. E., Moss S. E. The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes Metab Rev. 1989 Nov;5(7):559–570. doi: 10.1002/dmr.5610050703. [DOI] [PubMed] [Google Scholar]
  41. Klein R., Klein B. E., Neider M. W., Hubbard L. D., Meuer S. M., Brothers R. J. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology. 1985 Apr;92(4):485–491. doi: 10.1016/s0161-6420(85)34003-4. [DOI] [PubMed] [Google Scholar]
  42. Klein R., Moss S. E., Klein B. E., Davis M. D., DeMets D. L. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology. 1989 Oct;96(10):1501–1510. doi: 10.1016/s0161-6420(89)32699-6. [DOI] [PubMed] [Google Scholar]
  43. Kreisberg R. A. The second-generation sulfonylureas: change or progress? Ann Intern Med. 1985 Jan;102(1):125–126. doi: 10.7326/0003-4819-102-1-125. [DOI] [PubMed] [Google Scholar]
  44. Krolewski A. S., Kosinski E. J., Warram J. H., Leland O. S., Busick E. J., Asmal A. C., Rand L. I., Christlieb A. R., Bradley R. F., Kahn C. R. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol. 1987 Apr 1;59(8):750–755. doi: 10.1016/0002-9149(87)91086-1. [DOI] [PubMed] [Google Scholar]
  45. Larochelle P., Bass M. J., Birkett N. J., De Champlain J., Myers M. G. Recommendations from the Consensus Conference on Hypertension in the Elderly. CMAJ. 1986 Oct 1;135(7):741–745. [PMC free article] [PubMed] [Google Scholar]
  46. Macaulay A. C., Montour L. T., Adelson N. Prevalence of diabetic and atherosclerotic complications among Mohawk Indians of Kahnawake, PQ. CMAJ. 1988 Aug 1;139(3):221–224. [PMC free article] [PubMed] [Google Scholar]
  47. Makita Z., Radoff S., Rayfield E. J., Yang Z., Skolnik E., Delaney V., Friedman E. A., Cerami A., Vlassara H. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med. 1991 Sep 19;325(12):836–842. doi: 10.1056/NEJM199109193251202. [DOI] [PubMed] [Google Scholar]
  48. Marre M., Leblanc H., Suarez L., Guyenne T. T., Ménard J., Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res Ed) 1987 Jun 6;294(6585):1448–1452. doi: 10.1136/bmj.294.6585.1448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Max M. B., Culnane M., Schafer S. C., Gracely R. H., Walther D. J., Smoller B., Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987 Apr;37(4):589–596. doi: 10.1212/wnl.37.4.589. [DOI] [PubMed] [Google Scholar]
  50. McInnes G. T., Brodie M. J. Drug interactions that matter. A critical reappraisal. Drugs. 1988 Jul;36(1):83–110. doi: 10.2165/00003495-198836010-00006. [DOI] [PubMed] [Google Scholar]
  51. McNeer J. F., Margolis J. R., Lee K. L., Kisslo J. A., Peter R. H., Kong Y., Behar V. S., Wallace A. G., McCants C. B., Rosati R. A. The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation. 1978 Jan;57(1):64–70. doi: 10.1161/01.cir.57.1.64. [DOI] [PubMed] [Google Scholar]
  52. Miller L. V., Goldstein J. More efficient care of diabetic patients in a county-hospital setting. N Engl J Med. 1972 Jun 29;286(26):1388–1391. doi: 10.1056/NEJM197206292862605. [DOI] [PubMed] [Google Scholar]
  53. Minaker K. L., Rowe J. W., Tonino R., Pallotta J. A. Influence of age on clearance of insulin in man. Diabetes. 1982 Oct;31(10):851–855. doi: 10.2337/diab.31.10.851. [DOI] [PubMed] [Google Scholar]
  54. Mogensen C. E., Chachati A., Christensen C. K., Close C. F., Deckert T., Hommel E., Kastrup J., Lefebvre P., Mathiesen E. R., Feldt-Rasmussen B. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1985;9(2):85–95. doi: 10.3109/08860228509088195. [DOI] [PubMed] [Google Scholar]
  55. Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984 Jul 12;311(2):89–93. doi: 10.1056/NEJM198407123110204. [DOI] [PubMed] [Google Scholar]
  56. Mogensen C. E. Management of diabetic renal involvement and disease. Lancet. 1988 Apr 16;1(8590):867–870. doi: 10.1016/s0140-6736(88)91611-x. [DOI] [PubMed] [Google Scholar]
  57. Morrish N. J., Stevens L. K., Head J., Fuller J. H., Jarrett R. J., Keen H. A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates. Diabetologia. 1990 Sep;33(9):538–541. doi: 10.1007/BF00404141. [DOI] [PubMed] [Google Scholar]
  58. Moss S. E., Klein R., Klein B. E. The incidence of vision loss in a diabetic population. Ophthalmology. 1988 Oct;95(10):1340–1348. doi: 10.1016/s0161-6420(88)32991-x. [DOI] [PubMed] [Google Scholar]
  59. Moy C. S., LaPorte R. E., Dorman J. S., Songer T. J., Orchard T. J., Kuller L. H., Becker D. J., Drash A. L. Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking. Circulation. 1990 Jul;82(1):37–43. doi: 10.1161/01.cir.82.1.37. [DOI] [PubMed] [Google Scholar]
  60. Myers M. G., Carruthers S. G., Leenen F. H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ. 1989 May 15;140(10):1141–1146. [PMC free article] [PubMed] [Google Scholar]
  61. Naylor C. D. Diagnosing gestational diabetes mellitus. Is the gold standard valid? Diabetes Care. 1989 Sep;12(8):565–572. doi: 10.2337/diacare.12.8.565. [DOI] [PubMed] [Google Scholar]
  62. Olefsky J. M., Kolterman O. G. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med. 1981 Jan;70(1):151–168. doi: 10.1016/0002-9343(81)90422-8. [DOI] [PubMed] [Google Scholar]
  63. Parving H. H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care. 1991 Mar;14(3):260–269. doi: 10.2337/diacare.14.3.260. [DOI] [PubMed] [Google Scholar]
  64. Peters A. L., Davidson M. B. Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann Intern Med. 1991 Jul 1;115(1):45–53. doi: 10.7326/0003-4819-115-1-45. [DOI] [PubMed] [Google Scholar]
  65. Puxty J. A., Hunter D. H., Burr W. A. Accuracy of insulin injection in elderly patients. Br Med J (Clin Res Ed) 1983 Dec 10;287(6407):1762–1762. doi: 10.1136/bmj.287.6407.1762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Pyörälä K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987 Apr;3(2):463–524. doi: 10.1002/dmr.5610030206. [DOI] [PubMed] [Google Scholar]
  67. Reaven G. M. Beneficial effect of moderate weight loss in older patients with non-insulin-dependent diabetes mellitus poorly controlled with insulin. J Am Geriatr Soc. 1985 Feb;33(2):93–95. doi: 10.1111/j.1532-5415.1985.tb02272.x. [DOI] [PubMed] [Google Scholar]
  68. Riddle M. C., Hart J. S., Bouma D. J., Phillipson B. E., Youker G. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects. Diabetes Care. 1989 Oct;12(9):623–629. doi: 10.2337/diacare.12.9.623. [DOI] [PubMed] [Google Scholar]
  69. Rosenberg L., Palmer J. R., Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med. 1990 Jan 25;322(4):213–217. doi: 10.1056/NEJM199001253220401. [DOI] [PubMed] [Google Scholar]
  70. Rosenthal M. J., Hartnell J. M., Morley J. E., Mooradian A. D., Fiatarone M., Kaiser F. E., Osterweil D. UCLA geriatric grand rounds: diabetes in the elderly. J Am Geriatr Soc. 1987 May;35(5):435–447. doi: 10.1111/j.1532-5415.1987.tb04666.x. [DOI] [PubMed] [Google Scholar]
  71. Rytter L., Troelsen S., Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care. 1985 May-Jun;8(3):230–234. doi: 10.2337/diacare.8.3.230. [DOI] [PubMed] [Google Scholar]
  72. Sacks D. A., Abu-Fadil S., Greenspoon J. S., Fotheringham N. How reliable is the fifty-gram, one-hour glucose screening test? Am J Obstet Gynecol. 1989 Sep;161(3):642–645. doi: 10.1016/0002-9378(89)90370-0. [DOI] [PubMed] [Google Scholar]
  73. Schneider S. H., Amorosa L. F., Khachadurian A. K., Ruderman N. B. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1984 May;26(5):355–360. doi: 10.1007/BF00266036. [DOI] [PubMed] [Google Scholar]
  74. Seals D. R., Hagberg J. M., Hurley B. F., Ehsani A. A., Holloszy J. O. Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women. JAMA. 1984 Aug 3;252(5):645–649. [PubMed] [Google Scholar]
  75. Skarfors E. T., Wegener T. A., Lithell H., Selinus I. Physical training as treatment for type 2 (non-insulin-dependent) diabetes in elderly men. A feasibility study over 2 years. Diabetologia. 1987 Dec;30(12):930–933. doi: 10.1007/BF00295876. [DOI] [PubMed] [Google Scholar]
  76. Sperling M. A. Outpatient management of diabetes mellitus. Pediatr Clin North Am. 1987 Aug;34(4):919–934. doi: 10.1016/s0031-3955(16)36295-2. [DOI] [PubMed] [Google Scholar]
  77. Tallarigo L., Giampietro O., Penno G., Miccoli R., Gregori G., Navalesi R. Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med. 1986 Oct 16;315(16):989–992. doi: 10.1056/NEJM198610163151603. [DOI] [PubMed] [Google Scholar]
  78. Teuscher A., Egger M., Herman J. B. Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population. Arch Intern Med. 1989 Sep;149(9):1942–1945. doi: 10.1001/archinte.149.9.1942. [DOI] [PubMed] [Google Scholar]
  79. Trischitta V., Italia S., Borzi V., Tribulato A., Mazzarino S., Squatrito S., Vigneri R. Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care. 1989 Sep;12(8):582–585. doi: 10.2337/diacare.12.8.582. [DOI] [PubMed] [Google Scholar]
  80. Turner R. C., Holman R. R. Insulin use in NIDDM. Rationale based on pathophysiology of disease. Diabetes Care. 1990 Sep;13(9):1011–1020. doi: 10.2337/diacare.13.9.1011. [DOI] [PubMed] [Google Scholar]
  81. Tuttle K. R., DeFronzo R. A., Stein J. H. Treatment of diabetic nephropathy: a rational approach based on its pathophysiology. Semin Nephrol. 1991 Mar;11(2):220–235. [PubMed] [Google Scholar]
  82. Wilson P. W., Anderson K. M., Kannel W. B. Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am J Med. 1986 May 16;80(5A):3–9. doi: 10.1016/0002-9343(86)90532-2. [DOI] [PubMed] [Google Scholar]
  83. Wu M. S., Johnston P., Sheu W. H., Hollenbeck C. B., Jeng C. Y., Goldfine I. D., Chen Y. D., Reaven G. M. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care. 1990 Jan;13(1):1–8. doi: 10.2337/diacare.13.1.1. [DOI] [PubMed] [Google Scholar]
  84. Young T. K., McIntyre L. L., Dooley J., Rodriguez J. Epidemiologic features of diabetes mellitus among Indians in northwestern Ontario and northeastern Manitoba. Can Med Assoc J. 1985 Apr 1;132(7):793–797. [PMC free article] [PubMed] [Google Scholar]
  85. Young T. K., Szathmary E. J., Evers S., Wheatley B. Geographical distribution of diabetes among the native population of Canada: a national survey. Soc Sci Med. 1990;31(2):129–139. doi: 10.1016/0277-9536(90)90054-v. [DOI] [PubMed] [Google Scholar]
  86. Zinman B., Zuniga-Guajardo S., Kelly D. Comparison of the acute and long-term effects of exercise on glucose control in type I diabetes. Diabetes Care. 1984 Nov-Dec;7(6):515–519. doi: 10.2337/diacare.7.6.515. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES